<DOC>
	<DOCNO>NCT01670058</DOCNO>
	<brief_summary>- The prevalence Belatacept use - The characteristic Belatacept user temporal trend characteristic - Characteristics adult kidney-only transplant recipient treat Belatacept vs. treat Calcineurin inhibitor ( CNI ) -based regimens time transplantation , temporal trend characteristic 7 year post approval Belatacept .</brief_summary>
	<brief_title>Pattern Of Use Of Belatacept In US Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Abatacept</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com . The cohort analyse transplant include organ transplant recipient report Belatacept transplant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>